ProductLife Group Acquires Stragen Services
Deal News | Jan 28, 2025 | Globenewswire
ProductLife Group (PLG), a leading provider of consultancy services in regulatory, scientific, compliance, and digital transformation for the life sciences industry, has announced the acquisition of Stragen Services. A specialization of the Stragen Group, a renowned European platform for specialty generics supported by the global private equity firm ARCHIMED, Stragen Services has established itself as a critical partner in the fields of pharmacovigilance and clinical safety since its inception in 2009 in Lyon, France. With 36 employees, the firm is recognized for its bespoke advisory services. The acquisition enables PLG to expand in these essential areas, ensuring product accessibility, compliance, and safety on global markets. Stéphanie Collomb Gilbert, General Manager of Stragen Services, emphasizes that joining PLG represents a strategic move to enhance their capabilities and customer support through PLG's vast infrastructure. Xavier Duburcq, CEO of PLG, asserts that this acquisition confirms PLG's leadership in pharmacovigilance in the French and European markets, reinforcing their commitment to deliver premier support to clients. Jean-Yves Desmottes, Partner at ARCHIMED, notes that the acquisition opens significant opportunities for Stragen Services employees to maintain their standard of excellence and expand in their next growth phase. PLG aims to facilitate access to safe healthcare solutions worldwide and maintain its position as a strategic reference partner in the life sciences industry with expertise in over 150 countries.
Sectors
- Life Sciences
- Private Equity
- Pharmaceuticals
Geography
- France – Both ProductLife Group and Stragen Services have operations centered in France, making it a focal point of the acquisition.
- Europe – The acquisition significantly strengthens PLG's position in the European market, emphasizing its strategic growth within the continent.
Industry
- Life Sciences – The article discusses the acquisition of a company involved in pharmacovigilance and clinical safety, which are integral parts of the life sciences industry.
- Private Equity – ARCHIMED, the private equity firm supporting Stragen Group, is involved, highlighting the role of private equity in facilitating acquisitions and supporting business growth in the healthcare sector.
- Pharmaceuticals – Stragen Services operates within the pharmaceutical sector, offering specialized services like pharmacovigilance and clinical safety.
Financials
Participants
Name | Role | Type | Description |
---|---|---|---|
ProductLife Group (PLG) | Acquirer | Company | A global consultancy service provider in the life sciences sector, focusing on regulatory, compliance, scientific, and digital transformation services. |
Stragen Services | Target | Company | A division of the Stragen Group specializing in pharmacovigilance and clinical safety, based in Lyon, France. |
ARCHIMED | Private Equity Backer | Company | A global private equity firm focusing on healthcare, supporting the Stragen Group in its strategic operations. |
Stéphanie Collomb Gilbert | General Manager of Stragen Services | Person | Commented on the strategic importance of joining PLG for Stragen Services and its team. |
Xavier Duburcq | CEO of ProductLife Group | Person | Emphasized the significance of the acquisition for PLG's growth and leadership in pharmacovigilance. |
Jean-Yves Desmottes | Partner at ARCHIMED | Person | Highlighted the opportunities the acquisition presents for Stragen Services' growth and standard of excellence. |